Kainos Laboratories Liabilities 2024

Liabilities Details

Assessing Kainos Laboratories's Liabilities

Kainos Laboratories's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Kainos Laboratories's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Kainos Laboratories's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Kainos Laboratories's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Kainos Laboratories’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Kainos Laboratories Stock

What is the level of liabilities of Kainos Laboratories this year?

Kainos Laboratories has a debt balance of 2.32 B JPY this year.

What were the liabilities of Kainos Laboratories compared to the previous year?

The liabilities of Kainos Laboratories have increased by -1.97% dropped compared to the previous year.

What are the consequences of high debt for investors of Kainos Laboratories?

High liabilities can pose a risk for investors of Kainos Laboratories, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Kainos Laboratories?

Low liabilities mean that Kainos Laboratories has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Kainos Laboratories affect the company?

An increase in liabilities of Kainos Laboratories can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Kainos Laboratories affect the company?

A decrease in the liabilities of Kainos Laboratories can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Kainos Laboratories?

Some factors that can influence the liabilities of Kainos Laboratories include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Kainos Laboratories so important for investors?

The liabilities of Kainos Laboratories are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Kainos Laboratories take to modify the liabilities?

To change its liabilities, Kainos Laboratories can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Kainos Laboratories pay?

Over the past 12 months, Kainos Laboratories paid a dividend of 32 JPY . This corresponds to a dividend yield of about 2.71 %. For the coming 12 months, Kainos Laboratories is expected to pay a dividend of 32 JPY.

What is the dividend yield of Kainos Laboratories?

The current dividend yield of Kainos Laboratories is 2.71 %.

When does Kainos Laboratories pay dividends?

Kainos Laboratories pays a quarterly dividend. This is distributed in the months of April, April, April, April.

How secure is the dividend of Kainos Laboratories?

Kainos Laboratories paid dividends every year for the past 16 years.

What is the dividend of Kainos Laboratories?

For the upcoming 12 months, dividends amounting to 32 JPY are expected. This corresponds to a dividend yield of 2.71 %.

In which sector is Kainos Laboratories located?

Kainos Laboratories is assigned to the 'Health' sector.

Wann musste ich die Aktien von Kainos Laboratories kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Kainos Laboratories from 6/1/2024 amounting to 32 JPY, you needed to have the stock in your portfolio before the ex-date on 3/28/2024.

When did Kainos Laboratories pay the last dividend?

The last dividend was paid out on 6/1/2024.

What was the dividend of Kainos Laboratories in the year 2023?

In the year 2023, Kainos Laboratories distributed 25 JPY as dividends.

In which currency does Kainos Laboratories pay out the dividend?

The dividends of Kainos Laboratories are distributed in JPY.